Sequoia Financial Advisors LLC Has $708,000 Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Sequoia Financial Advisors LLC raised its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 12.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,824 shares of the company’s stock after buying an additional 1,120 shares during the period. Sequoia Financial Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $708,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PBH. Opal Wealth Advisors LLC bought a new stake in Prestige Consumer Healthcare during the 2nd quarter worth $26,000. Quest Partners LLC increased its stake in shares of Prestige Consumer Healthcare by 2,826.7% in the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after buying an additional 424 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Prestige Consumer Healthcare by 562.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock worth $35,000 after buying an additional 433 shares during the period. Finally, Gladius Capital Management LP bought a new stake in Prestige Consumer Healthcare during the 2nd quarter worth approximately $35,000. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Up 0.3 %

Shares of NYSE:PBH opened at $73.04 on Friday. Prestige Consumer Healthcare Inc. has a 1 year low of $56.61 and a 1 year high of $75.80. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The business’s 50-day moving average is $71.82 and its 200-day moving average is $69.39. The company has a market capitalization of $3.62 billion, a price-to-earnings ratio of 17.86, a P/E/G ratio of 2.03 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. The firm had revenue of $267.10 million for the quarter, compared to analysts’ expectations of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company’s revenue for the quarter was down 4.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.06 EPS. Equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson lifted their target price on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average price target of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.